Genome Editing/Genome Engineering Market - Global Outlook and Forecast 2022-2028
Genome editing technology refers to the ability of human to 'edit' the target gene, such as the deletion and addition of specific DNA fragments.
This report contains market size and forecasts of Genome Editing/Genome Engineering in Global, including the following market information:
Global Genome Editing/Genome Engineering Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Genome Editing/Genome Engineering market was valued at 3614.8 million in 2021 and is projected to reach US$ 6565.6 million by 2028, at a CAGR of 8.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CRISPR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genome Editing/Genome Engineering include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated Dna Technologies, Lonza, New England Biolabs and Origene Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genome Editing/Genome Engineering companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genome Editing/Genome Engineering Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Genome Editing/Genome Engineering Market Segment Percentages, by Type, 2021 (%)
Global Genome Editing/Genome Engineering Market Segment Percentages, by Application, 2021 (%)
Global Genome Editing/Genome Engineering Market Segment Percentages, By Region and Country, 2021 (%)
The report also provides analysis of leading market participants including:
Key companies Genome Editing/Genome Engineering revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Genome Editing/Genome Engineering revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
This report contains market size and forecasts of Genome Editing/Genome Engineering in Global, including the following market information:
Global Genome Editing/Genome Engineering Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Genome Editing/Genome Engineering market was valued at 3614.8 million in 2021 and is projected to reach US$ 6565.6 million by 2028, at a CAGR of 8.9% during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
CRISPR Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Genome Editing/Genome Engineering include Thermo Fisher Scientific, Merck, Horizon Discovery, Genscript, Sangamo Biosciences, Integrated Dna Technologies, Lonza, New England Biolabs and Origene Technologies, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Genome Editing/Genome Engineering companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Genome Editing/Genome Engineering Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Genome Editing/Genome Engineering Market Segment Percentages, by Type, 2021 (%)
- CRISPR
- TALEN
- ZFN
Global Genome Editing/Genome Engineering Market Segment Percentages, by Application, 2021 (%)
- Cell Line Engineering
- Animal Genetic Engineering
- Plant Genetic Engineering
Global Genome Editing/Genome Engineering Market Segment Percentages, By Region and Country, 2021 (%)
- North America
- US
- Canada
- Mexico
- Europe
- Germany
- France
- U.K.
- Italy
- Russia
- Nordic Countries
- Benelux
- Rest of Europe
- Asia
- China
- Japan
- South Korea
- Southeast Asia
- India
- Rest of Asia
- South America
- Brazil
- Argentina
- Rest of South America
- Middle East & Africa
- Turkey
- Israel
- Saudi Arabia
- UAE
- Rest of Middle East & Africa
The report also provides analysis of leading market participants including:
Key companies Genome Editing/Genome Engineering revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Genome Editing/Genome Engineering revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
- Thermo Fisher Scientific
- Merck
- Horizon Discovery
- Genscript
- Sangamo Biosciences
- Integrated Dna Technologies
- Lonza
- New England Biolabs
- Origene Technologies
- Transposagen Biopharmaceuticals
- Editas Medicine
- Crispr Therapeutics
1 INTRODUCTION TO RESEARCH & ANALYSIS REPORTS
1.1 Genome Editing/Genome Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genome Editing/Genome Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GENOME EDITING/GENOME ENGINEERING OVERALL MARKET SIZE
2.1 Global Genome Editing/Genome Engineering Market Size: 2021 VS 2028
2.2 Global Genome Editing/Genome Engineering Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Genome Editing/Genome Engineering Players in Global Market
3.2 Top Global Genome Editing/Genome Engineering Companies Ranked by Revenue
3.3 Global Genome Editing/Genome Engineering Revenue by Companies
3.4 Top 3 and Top 5 Genome Editing/Genome Engineering Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genome Editing/Genome Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genome Editing/Genome Engineering Players in Global Market
3.6.1 List of Global Tier 1 Genome Editing/Genome Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Genome Editing/Genome Engineering Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Genome Editing/Genome Engineering Market Size Markets, 2021 & 2028
4.1.2 CRISPR
4.1.3 TALEN
4.1.4 ZFN
4.2 By Type - Global Genome Editing/Genome Engineering Revenue & Forecasts
4.2.1 By Type - Global Genome Editing/Genome Engineering Revenue, 2017-2022
4.2.2 By Type - Global Genome Editing/Genome Engineering Revenue, 2023-2028
4.2.3 By Type - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Genome Editing/Genome Engineering Market Size, 2021 & 2028
5.1.2 Cell Line Engineering
5.1.3 Animal Genetic Engineering
5.1.4 Plant Genetic Engineering
5.2 By Application - Global Genome Editing/Genome Engineering Revenue & Forecasts
5.2.1 By Application - Global Genome Editing/Genome Engineering Revenue, 2017-2022
5.2.2 By Application - Global Genome Editing/Genome Engineering Revenue, 2023-2028
5.2.3 By Application - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Genome Editing/Genome Engineering Market Size, 2021 & 2028
6.2 By Region - Global Genome Editing/Genome Engineering Revenue & Forecasts
6.2.1 By Region - Global Genome Editing/Genome Engineering Revenue, 2017-2022
6.2.2 By Region - Global Genome Editing/Genome Engineering Revenue, 2023-2028
6.2.3 By Region - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Genome Editing/Genome Engineering Revenue, 2017-2028
6.3.2 US Genome Editing/Genome Engineering Market Size, 2017-2028
6.3.3 Canada Genome Editing/Genome Engineering Market Size, 2017-2028
6.3.4 Mexico Genome Editing/Genome Engineering Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Genome Editing/Genome Engineering Revenue, 2017-2028
6.4.2 Germany Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.3 France Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.4 U.K. Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.5 Italy Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.6 Russia Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.7 Nordic Countries Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.8 Benelux Genome Editing/Genome Engineering Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Genome Editing/Genome Engineering Revenue, 2017-2028
6.5.2 China Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.3 Japan Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.4 South Korea Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.5 Southeast Asia Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.6 India Genome Editing/Genome Engineering Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Genome Editing/Genome Engineering Revenue, 2017-2028
6.6.2 Brazil Genome Editing/Genome Engineering Market Size, 2017-2028
6.6.3 Argentina Genome Editing/Genome Engineering Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, 2017-2028
6.7.2 Turkey Genome Editing/Genome Engineering Market Size, 2017-2028
6.7.3 Israel Genome Editing/Genome Engineering Market Size, 2017-2028
6.7.4 Saudi Arabia Genome Editing/Genome Engineering Market Size, 2017-2028
6.7.5 UAE Genome Editing/Genome Engineering Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Major Product Offerings
7.1.4 Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Genome Editing/Genome Engineering Major Product Offerings
7.2.4 Merck Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Horizon Discovery
7.3.1 Horizon Discovery Corporate Summary
7.3.2 Horizon Discovery Business Overview
7.3.3 Horizon Discovery Genome Editing/Genome Engineering Major Product Offerings
7.3.4 Horizon Discovery Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.3.5 Horizon Discovery Key News
7.4 Genscript
7.4.1 Genscript Corporate Summary
7.4.2 Genscript Business Overview
7.4.3 Genscript Genome Editing/Genome Engineering Major Product Offerings
7.4.4 Genscript Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.4.5 Genscript Key News
7.5 Sangamo Biosciences
7.5.1 Sangamo Biosciences Corporate Summary
7.5.2 Sangamo Biosciences Business Overview
7.5.3 Sangamo Biosciences Genome Editing/Genome Engineering Major Product Offerings
7.5.4 Sangamo Biosciences Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.5.5 Sangamo Biosciences Key News
7.6 Integrated Dna Technologies
7.6.1 Integrated Dna Technologies Corporate Summary
7.6.2 Integrated Dna Technologies Business Overview
7.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Major Product Offerings
7.6.4 Integrated Dna Technologies Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.6.5 Integrated Dna Technologies Key News
7.7 Lonza
7.7.1 Lonza Corporate Summary
7.7.2 Lonza Business Overview
7.7.3 Lonza Genome Editing/Genome Engineering Major Product Offerings
7.7.4 Lonza Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.7.5 Lonza Key News
7.8 New England Biolabs
7.8.1 New England Biolabs Corporate Summary
7.8.2 New England Biolabs Business Overview
7.8.3 New England Biolabs Genome Editing/Genome Engineering Major Product Offerings
7.8.4 New England Biolabs Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.8.5 New England Biolabs Key News
7.9 Origene Technologies
7.9.1 Origene Technologies Corporate Summary
7.9.2 Origene Technologies Business Overview
7.9.3 Origene Technologies Genome Editing/Genome Engineering Major Product Offerings
7.9.4 Origene Technologies Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.9.5 Origene Technologies Key News
7.10 Transposagen Biopharmaceuticals
7.10.1 Transposagen Biopharmaceuticals Corporate Summary
7.10.2 Transposagen Biopharmaceuticals Business Overview
7.10.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Major Product Offerings
7.10.4 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.10.5 Transposagen Biopharmaceuticals Key News
7.11 Editas Medicine
7.11.1 Editas Medicine Corporate Summary
7.11.2 Editas Medicine Business Overview
7.11.3 Editas Medicine Genome Editing/Genome Engineering Major Product Offerings
7.11.4 Editas Medicine Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.11.5 Editas Medicine Key News
7.12 Crispr Therapeutics
7.12.1 Crispr Therapeutics Corporate Summary
7.12.2 Crispr Therapeutics Business Overview
7.12.3 Crispr Therapeutics Genome Editing/Genome Engineering Major Product Offerings
7.12.4 Crispr Therapeutics Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.12.5 Crispr Therapeutics Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
1.1 Genome Editing/Genome Engineering Market Definition
1.2 Market Segments
1.2.1 Market by Type
1.2.2 Market by Application
1.3 Global Genome Editing/Genome Engineering Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 GLOBAL GENOME EDITING/GENOME ENGINEERING OVERALL MARKET SIZE
2.1 Global Genome Editing/Genome Engineering Market Size: 2021 VS 2028
2.2 Global Genome Editing/Genome Engineering Market Size, Prospects & Forecasts: 2017-2028
2.3 Key Market Trends, Opportunity, Drivers and Restraints
2.3.1 Market Opportunities & Trends
2.3.2 Market Drivers
2.3.3 Market Restraints
3 COMPANY LANDSCAPE
3.1 Top Genome Editing/Genome Engineering Players in Global Market
3.2 Top Global Genome Editing/Genome Engineering Companies Ranked by Revenue
3.3 Global Genome Editing/Genome Engineering Revenue by Companies
3.4 Top 3 and Top 5 Genome Editing/Genome Engineering Companies in Global Market, by Revenue in 2021
3.5 Global Companies Genome Editing/Genome Engineering Product Type
3.6 Tier 1, Tier 2 and Tier 3 Genome Editing/Genome Engineering Players in Global Market
3.6.1 List of Global Tier 1 Genome Editing/Genome Engineering Companies
3.6.2 List of Global Tier 2 and Tier 3 Genome Editing/Genome Engineering Companies
4 MARKET SIGHTS BY PRODUCT
4.1 Overview
4.1.1 by Type - Global Genome Editing/Genome Engineering Market Size Markets, 2021 & 2028
4.1.2 CRISPR
4.1.3 TALEN
4.1.4 ZFN
4.2 By Type - Global Genome Editing/Genome Engineering Revenue & Forecasts
4.2.1 By Type - Global Genome Editing/Genome Engineering Revenue, 2017-2022
4.2.2 By Type - Global Genome Editing/Genome Engineering Revenue, 2023-2028
4.2.3 By Type - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
5 SIGHTS BY APPLICATION
5.1 Overview
5.1.1 By Application - Global Genome Editing/Genome Engineering Market Size, 2021 & 2028
5.1.2 Cell Line Engineering
5.1.3 Animal Genetic Engineering
5.1.4 Plant Genetic Engineering
5.2 By Application - Global Genome Editing/Genome Engineering Revenue & Forecasts
5.2.1 By Application - Global Genome Editing/Genome Engineering Revenue, 2017-2022
5.2.2 By Application - Global Genome Editing/Genome Engineering Revenue, 2023-2028
5.2.3 By Application - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
6 SIGHTS BY REGION
6.1 By Region - Global Genome Editing/Genome Engineering Market Size, 2021 & 2028
6.2 By Region - Global Genome Editing/Genome Engineering Revenue & Forecasts
6.2.1 By Region - Global Genome Editing/Genome Engineering Revenue, 2017-2022
6.2.2 By Region - Global Genome Editing/Genome Engineering Revenue, 2023-2028
6.2.3 By Region - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
6.3 North America
6.3.1 By Country - North America Genome Editing/Genome Engineering Revenue, 2017-2028
6.3.2 US Genome Editing/Genome Engineering Market Size, 2017-2028
6.3.3 Canada Genome Editing/Genome Engineering Market Size, 2017-2028
6.3.4 Mexico Genome Editing/Genome Engineering Market Size, 2017-2028
6.4 Europe
6.4.1 By Country - Europe Genome Editing/Genome Engineering Revenue, 2017-2028
6.4.2 Germany Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.3 France Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.4 U.K. Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.5 Italy Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.6 Russia Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.7 Nordic Countries Genome Editing/Genome Engineering Market Size, 2017-2028
6.4.8 Benelux Genome Editing/Genome Engineering Market Size, 2017-2028
6.5 Asia
6.5.1 By Region - Asia Genome Editing/Genome Engineering Revenue, 2017-2028
6.5.2 China Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.3 Japan Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.4 South Korea Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.5 Southeast Asia Genome Editing/Genome Engineering Market Size, 2017-2028
6.5.6 India Genome Editing/Genome Engineering Market Size, 2017-2028
6.6 South America
6.6.1 By Country - South America Genome Editing/Genome Engineering Revenue, 2017-2028
6.6.2 Brazil Genome Editing/Genome Engineering Market Size, 2017-2028
6.6.3 Argentina Genome Editing/Genome Engineering Market Size, 2017-2028
6.7 Middle East & Africa
6.7.1 By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, 2017-2028
6.7.2 Turkey Genome Editing/Genome Engineering Market Size, 2017-2028
6.7.3 Israel Genome Editing/Genome Engineering Market Size, 2017-2028
6.7.4 Saudi Arabia Genome Editing/Genome Engineering Market Size, 2017-2028
6.7.5 UAE Genome Editing/Genome Engineering Market Size, 2017-2028
7 PLAYERS PROFILES
7.1 Thermo Fisher Scientific
7.1.1 Thermo Fisher Scientific Corporate Summary
7.1.2 Thermo Fisher Scientific Business Overview
7.1.3 Thermo Fisher Scientific Genome Editing/Genome Engineering Major Product Offerings
7.1.4 Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.1.5 Thermo Fisher Scientific Key News
7.2 Merck
7.2.1 Merck Corporate Summary
7.2.2 Merck Business Overview
7.2.3 Merck Genome Editing/Genome Engineering Major Product Offerings
7.2.4 Merck Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.2.5 Merck Key News
7.3 Horizon Discovery
7.3.1 Horizon Discovery Corporate Summary
7.3.2 Horizon Discovery Business Overview
7.3.3 Horizon Discovery Genome Editing/Genome Engineering Major Product Offerings
7.3.4 Horizon Discovery Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.3.5 Horizon Discovery Key News
7.4 Genscript
7.4.1 Genscript Corporate Summary
7.4.2 Genscript Business Overview
7.4.3 Genscript Genome Editing/Genome Engineering Major Product Offerings
7.4.4 Genscript Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.4.5 Genscript Key News
7.5 Sangamo Biosciences
7.5.1 Sangamo Biosciences Corporate Summary
7.5.2 Sangamo Biosciences Business Overview
7.5.3 Sangamo Biosciences Genome Editing/Genome Engineering Major Product Offerings
7.5.4 Sangamo Biosciences Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.5.5 Sangamo Biosciences Key News
7.6 Integrated Dna Technologies
7.6.1 Integrated Dna Technologies Corporate Summary
7.6.2 Integrated Dna Technologies Business Overview
7.6.3 Integrated Dna Technologies Genome Editing/Genome Engineering Major Product Offerings
7.6.4 Integrated Dna Technologies Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.6.5 Integrated Dna Technologies Key News
7.7 Lonza
7.7.1 Lonza Corporate Summary
7.7.2 Lonza Business Overview
7.7.3 Lonza Genome Editing/Genome Engineering Major Product Offerings
7.7.4 Lonza Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.7.5 Lonza Key News
7.8 New England Biolabs
7.8.1 New England Biolabs Corporate Summary
7.8.2 New England Biolabs Business Overview
7.8.3 New England Biolabs Genome Editing/Genome Engineering Major Product Offerings
7.8.4 New England Biolabs Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.8.5 New England Biolabs Key News
7.9 Origene Technologies
7.9.1 Origene Technologies Corporate Summary
7.9.2 Origene Technologies Business Overview
7.9.3 Origene Technologies Genome Editing/Genome Engineering Major Product Offerings
7.9.4 Origene Technologies Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.9.5 Origene Technologies Key News
7.10 Transposagen Biopharmaceuticals
7.10.1 Transposagen Biopharmaceuticals Corporate Summary
7.10.2 Transposagen Biopharmaceuticals Business Overview
7.10.3 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Major Product Offerings
7.10.4 Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.10.5 Transposagen Biopharmaceuticals Key News
7.11 Editas Medicine
7.11.1 Editas Medicine Corporate Summary
7.11.2 Editas Medicine Business Overview
7.11.3 Editas Medicine Genome Editing/Genome Engineering Major Product Offerings
7.11.4 Editas Medicine Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.11.5 Editas Medicine Key News
7.12 Crispr Therapeutics
7.12.1 Crispr Therapeutics Corporate Summary
7.12.2 Crispr Therapeutics Business Overview
7.12.3 Crispr Therapeutics Genome Editing/Genome Engineering Major Product Offerings
7.12.4 Crispr Therapeutics Genome Editing/Genome Engineering Revenue in Global Market (2017-2022)
7.12.5 Crispr Therapeutics Key News
8 CONCLUSION
9 APPENDIX
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
LIST OF TABLES
Table 1. Genome Editing/Genome Engineering Market Opportunities & Trends in Global Market
Table 2. Genome Editing/Genome Engineering Market Drivers in Global Market
Table 3. Genome Editing/Genome Engineering Market Restraints in Global Market
Table 4. Key Players of Genome Editing/Genome Engineering in Global Market
Table 5. Top Genome Editing/Genome Engineering Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genome Editing/Genome Engineering Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genome Editing/Genome Engineering Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genome Editing/Genome Engineering Product Type
Table 9. List of Global Tier 1 Genome Editing/Genome Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genome Editing/Genome Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genome Editing/Genome Engineering Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genome Editing/Genome Engineering Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Genome Editing/Genome Engineering Product Offerings
Table 32. Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Genome Editing/Genome Engineering Product Offerings
Table 35. Merck Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 36. Horizon Discovery Corporate Summary
Table 37. Horizon Discovery Genome Editing/Genome Engineering Product Offerings
Table 38. Horizon Discovery Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 39. Genscript Corporate Summary
Table 40. Genscript Genome Editing/Genome Engineering Product Offerings
Table 41. Genscript Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 42. Sangamo Biosciences Corporate Summary
Table 43. Sangamo Biosciences Genome Editing/Genome Engineering Product Offerings
Table 44. Sangamo Biosciences Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 45. Integrated Dna Technologies Corporate Summary
Table 46. Integrated Dna Technologies Genome Editing/Genome Engineering Product Offerings
Table 47. Integrated Dna Technologies Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 48. Lonza Corporate Summary
Table 49. Lonza Genome Editing/Genome Engineering Product Offerings
Table 50. Lonza Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 51. New England Biolabs Corporate Summary
Table 52. New England Biolabs Genome Editing/Genome Engineering Product Offerings
Table 53. New England Biolabs Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 54. Origene Technologies Corporate Summary
Table 55. Origene Technologies Genome Editing/Genome Engineering Product Offerings
Table 56. Origene Technologies Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 57. Transposagen Biopharmaceuticals Corporate Summary
Table 58. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product Offerings
Table 59. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 60. Editas Medicine Corporate Summary
Table 61. Editas Medicine Genome Editing/Genome Engineering Product Offerings
Table 62. Editas Medicine Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 63. Crispr Therapeutics Corporate Summary
Table 64. Crispr Therapeutics Genome Editing/Genome Engineering Product Offerings
Table 65. Crispr Therapeutics Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 1. Genome Editing/Genome Engineering Market Opportunities & Trends in Global Market
Table 2. Genome Editing/Genome Engineering Market Drivers in Global Market
Table 3. Genome Editing/Genome Engineering Market Restraints in Global Market
Table 4. Key Players of Genome Editing/Genome Engineering in Global Market
Table 5. Top Genome Editing/Genome Engineering Players in Global Market, Ranking by Revenue (2021)
Table 6. Global Genome Editing/Genome Engineering Revenue by Companies, (US$, Mn), 2017-2022
Table 7. Global Genome Editing/Genome Engineering Revenue Share by Companies, 2017-2022
Table 8. Global Companies Genome Editing/Genome Engineering Product Type
Table 9. List of Global Tier 1 Genome Editing/Genome Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 10. List of Global Tier 2 and Tier 3 Genome Editing/Genome Engineering Companies, Revenue (US$, Mn) in 2021 and Market Share
Table 11. By Type – Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 & 2028
Table 12. By Type - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2017-2022
Table 13. By Type - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2023-2028
Table 14. By Application – Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 & 2028
Table 15. By Application - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2017-2022
Table 16. By Application - Genome Editing/Genome Engineering Revenue in Global (US$, Mn), 2023-2028
Table 17. By Region – Global Genome Editing/Genome Engineering Revenue, (US$, Mn), 2021 & 2028
Table 18. By Region - Global Genome Editing/Genome Engineering Revenue (US$, Mn), 2017-2022
Table 19. By Region - Global Genome Editing/Genome Engineering Revenue (US$, Mn), 2023-2028
Table 20. By Country - North America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 21. By Country - North America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 22. By Country - Europe Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 23. By Country - Europe Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 24. By Region - Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 25. By Region - Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 26. By Country - South America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 27. By Country - South America Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 28. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2022
Table 29. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue, (US$, Mn), 2023-2028
Table 30. Thermo Fisher Scientific Corporate Summary
Table 31. Thermo Fisher Scientific Genome Editing/Genome Engineering Product Offerings
Table 32. Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 33. Merck Corporate Summary
Table 34. Merck Genome Editing/Genome Engineering Product Offerings
Table 35. Merck Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 36. Horizon Discovery Corporate Summary
Table 37. Horizon Discovery Genome Editing/Genome Engineering Product Offerings
Table 38. Horizon Discovery Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 39. Genscript Corporate Summary
Table 40. Genscript Genome Editing/Genome Engineering Product Offerings
Table 41. Genscript Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 42. Sangamo Biosciences Corporate Summary
Table 43. Sangamo Biosciences Genome Editing/Genome Engineering Product Offerings
Table 44. Sangamo Biosciences Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 45. Integrated Dna Technologies Corporate Summary
Table 46. Integrated Dna Technologies Genome Editing/Genome Engineering Product Offerings
Table 47. Integrated Dna Technologies Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 48. Lonza Corporate Summary
Table 49. Lonza Genome Editing/Genome Engineering Product Offerings
Table 50. Lonza Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 51. New England Biolabs Corporate Summary
Table 52. New England Biolabs Genome Editing/Genome Engineering Product Offerings
Table 53. New England Biolabs Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 54. Origene Technologies Corporate Summary
Table 55. Origene Technologies Genome Editing/Genome Engineering Product Offerings
Table 56. Origene Technologies Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 57. Transposagen Biopharmaceuticals Corporate Summary
Table 58. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Product Offerings
Table 59. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 60. Editas Medicine Corporate Summary
Table 61. Editas Medicine Genome Editing/Genome Engineering Product Offerings
Table 62. Editas Medicine Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
Table 63. Crispr Therapeutics Corporate Summary
Table 64. Crispr Therapeutics Genome Editing/Genome Engineering Product Offerings
Table 65. Crispr Therapeutics Genome Editing/Genome Engineering Revenue (US$, Mn), (2017-2022)
LIST OF FIGURES
Figure 1. Genome Editing/Genome Engineering Segment by Type in 2021
Figure 2. Genome Editing/Genome Engineering Segment by Application in 2021
Figure 3. Global Genome Editing/Genome Engineering Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Genome Editing/Genome Engineering Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genome Editing/Genome Engineering Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genome Editing/Genome Engineering Revenue in 2021
Figure 8. By Type - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 12. US Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 16. Germany Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 17. France Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 24. China Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 28. India Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 30. Brazil Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 33. Turkey Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Horizon Discovery Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Genscript Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sangamo Biosciences Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Integrated Dna Technologies Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lonza Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. New England Biolabs Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Origene Technologies Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Editas Medicine Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Crispr Therapeutics Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 1. Genome Editing/Genome Engineering Segment by Type in 2021
Figure 2. Genome Editing/Genome Engineering Segment by Application in 2021
Figure 3. Global Genome Editing/Genome Engineering Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Global Genome Editing/Genome Engineering Market Size: 2021 VS 2028 (US$, Mn)
Figure 6. Global Genome Editing/Genome Engineering Revenue, 2017-2028 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Genome Editing/Genome Engineering Revenue in 2021
Figure 8. By Type - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 9. By Application - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 10. By Region - Global Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 11. By Country - North America Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 12. US Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 13. Canada Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 14. Mexico Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 15. By Country - Europe Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 16. Germany Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 17. France Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 18. U.K. Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 19. Italy Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 20. Russia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 21. Nordic Countries Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 22. Benelux Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 23. By Region - Asia Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 24. China Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 25. Japan Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 26. South Korea Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 27. Southeast Asia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 28. India Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 29. By Country - South America Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 30. Brazil Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 31. Argentina Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 32. By Country - Middle East & Africa Genome Editing/Genome Engineering Revenue Market Share, 2017-2028
Figure 33. Turkey Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 34. Israel Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 35. Saudi Arabia Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 36. UAE Genome Editing/Genome Engineering Revenue, (US$, Mn), 2017-2028
Figure 37. Thermo Fisher Scientific Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 38. Merck Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 39. Horizon Discovery Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 40. Genscript Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 41. Sangamo Biosciences Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 42. Integrated Dna Technologies Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 43. Lonza Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 44. New England Biolabs Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 45. Origene Technologies Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 46. Transposagen Biopharmaceuticals Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 47. Editas Medicine Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)
Figure 48. Crispr Therapeutics Genome Editing/Genome Engineering Revenue Year Over Year Growth (US$, Mn) & (2017-2022)